Significant public health issues invariably arise, but the trajectory is not always obvious. Deborah Komlos of Clarivate discusses how such has been the case for …

Often thought of as a simple off-the-shelf product, clinical trials insurance can be considerably more complex, as Victoria Cockayne and Johannes Klose of Allianz explain. …

The drug discovery process is hugely data-intensive, making it an ideal application for artificial intelligence (AI) and machine learning. But it isn’t as straightforward as …

Working closely with regulators should be seen as an important strategy for successful drug development, rather than a barrier to be sidestepped or overcome. Early …

Cardiovascular disease remains public enemy number one in healthcare. Taking the top spot on the mortality scale, diseases of the heart are predicted to affect …

Colin Newbould of Wasdell talks through the vital considerations when packaging drugs for clinical supply. He discusses the various challenges presented by blinding, randomisation and …

Although the main purpose of most clinical trials is to compare the efficacy and/or safety endpoints that occur in two groups, the endpoint management and …

The influx of industry-sponsored research (ISR) into the Asia Pacific region is continually growing due to the rising costs and complicated processes involved in drug …

Malaria has been a major global health problem of humans throughout history and is a leading cause of death and disease across many tropical and …

By developing and bringing new oncology treatments to market, clinical researchers have an important role to play in helping reduce cancer-related mortality. But trials in …